The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Help Patients with Scleroderma Manage Musculoskeletal and Functional Limitations

Help Patients with Scleroderma Manage Musculoskeletal and Functional Limitations

February 1, 2009 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

On March 10, Janet Poole, PhD, OTR, professor of the occupational therapy graduate program at the University of New Mexico in Albuquerque, will continue the ARHP’s Audioconference/Webcast Series with the management of scleroderma. Dr. Poole received her BS in occupational therapy from Colorado State University, her MA degree in educational psychology from the University of North Carolina, Chapel Hill, and her PhD in motor learning/motor control from the University of Pittsburgh. Dr. Poole’s research interest is in scleroderma and the functional impact of the disease on the tasks of daily living, oral hygiene, parenting, and employment. She has conducted a number of studies examining rehabilitation interventions with people who have scleroderma and, with a colleague, is developing a self-management program for these patients. She has also authored several textbook chapters on rehabilitation for people with scleroderma.

You Might Also Like
  • Apply for ARHP’s Graduate Student Award
  • Living Well with Scleroderma
  • Preceptorship Applications Due February 1
Explore This Issue
February 2009
Also By This Author
  • SCHIP Legislation a Priority

Dr. Poole’s first introduction to patients with scleroderma started as an occupational therapist in 1984 when she met two doctors at the University of Pittsburgh that inspired her to examine hand functions in patients with scleroderma. During her studies, Dr. Poole became very intrigued with the difficulty patients were having with many of their daily routines and during leisure activities. She continued her research because there was very little being reported on patients with scleroderma to guide occupational and physical therapists.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“There are approximately 300,000 people in the U.S. who have scleroderma according to the Scleroderma Foundation, and it is very different from a lot of the other types of rheumatic diseases due to skin hardening, ulcers, and difficulty swallowing,” explains Dr. Poole. “Scleroderma is a connective tissue disease and calls for more aggressive stretching exercises when compared to other rheumatic diseases.”

The biggest portion of Dr. Poole’s discussion will focus on exercise, oral hygiene, and managing daily tasks. She will review the classification and symptoms of systemic sclerosis and discuss management strategies for joint motion, exercise, pain control, daily tasks including oral care, and fatigue. In addition, she will look at Raynaud’s phenomenon as it relates to these patients and will review the evidence for rehabilitation interventions.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

There are approximately 300,000 people in the U.S. who have scleroderma according to the Scleroderma Foundation, and it is very different from a lot of the other types of rheumatic diseases.

—Janet Poole, PhD, OTR

To register for the March 10 audioconference/ Webcast, contact Sharon Ross at (404) 633-3777, ext. 802 or visit www.rheumatology.org/arhp. CME and certificates of participation will be offered to paid registrants. If you are unable to participate, you can purchase a recording of the session at www.rheumatology.org/arhp.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: From the College Tagged With: Association of Rheumatology Professionals (ARP), Management, Scleroderma, TreatmentIssue: February 2009

You Might Also Like:
  • Apply for ARHP’s Graduate Student Award
  • Living Well with Scleroderma
  • Preceptorship Applications Due February 1
  • Graduate Student Award Mentors Needed

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)